← back to search

Hassan Mahomed

University of Cape Town · ZA
Area of research
Infectious Diseases · Immunology
Research interest
Research focused on Tuberculosis and Mycobacterium tuberculosis, with related work in Contact tracing, Immunology, Virology. Notable publications include 'A blood RNA signature for tuberculosis disease risk: a prospective cohort study', 'T-cell activation is an immune correlate of risk in BCG vaccinated infants', and 'First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults'.
h-index
citations
1,836
works
9
NIH funding
primary concept
email

Recent publications

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection
Nature Medicine 2023cited by 96position: middledoi
Contact Tracing and the COVID-19 Response in Africa: Best Practices, Key Challenges, and Lessons Learned from Nigeria, Rwanda, South Africa, and Uganda
American Journal of Tropical Medicine and Hygiene 2021cited by 105position: middledoi
From Easing Lockdowns to Scaling Up Community-based Coronavirus Disease 2019 Screening, Testing, and Contact Tracing in Africa—Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality
Clinical Infectious Diseases 2020cited by 65position: middledoi
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study
The Lancet Respiratory Medicine 2017cited by 148position: middledoi
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
The Lancet 2016cited by 813position: middledoi
T-cell activation is an immune correlate of risk in BCG vaccinated infants
Nature Communications 2016cited by 271position: middledoi
First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults
Vaccine 2015cited by 193position: middledoi
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A
BMC Infectious Diseases 2014cited by 28position: middledoi
Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults
American Journal of Respiratory and Critical Care Medicine 2013cited by 117position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Willem A. Hanekom · Africa Health Research Institute4 papers (2013–2017)Michèle Tameris · University of Cape Town4 papers (2013–2017)Lebohang Makhethe · University of Cape Town2 papers (2013–2015)Mark Hatherill · University of Cape Town2 papers (2015–2017)Jeanine Condo · Tulane University2 papers (2020–2021) · 2 papers (2020–2021)Jean B. Nachega · University of Pittsburgh2 papers (2020–2021)Hennie Geldenhuys · University of Cape Town2 papers (2013–2015)Cheryl L. Day · Emory University2 papers (2013–2015) · 2 papers (2020–2021)Michael Reid · University of California, San Francisco2 papers (2020–2021)Alimuddin Zumla · Semmelweis University2 papers (2020–2021)Thomas J. Scriba · South African Tuberculosis Vaccine Initiative2 papers (2015–2017)Gregory Hussey · University of Cape Town2 papers (2013–2015)Helen A. Fletcher · London School of Hygiene & Tropical Medicine2 papers (2014–2017)Sabin Nsanzimana · Brown University2 papers (2020–2021)E. Jane Hughes · University of Oxford2 papers (2013–2015)Helen McShane · University of Oxford2 papers (2014–2017)Elisma Schoeman · South African Tuberculosis Vaccine Initiative1 papers (2015–2015)Sara Suliman · University of Cape Town1 papers (2015–2015)